How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Robert L. Dixon, Jr. net worth and biography

Robert Dixon, Jr. Biography and Net Worth

Director of Elevance Health

Robert L. Dixon Jr. serves as Independent Director of the Company. Mr. Dixon joined our board in June 2019. Mr. Dixon has owned The RD Factor, Inc., a digital and information technology consulting business, since December 2016. Mr. Dixon served at PepsiCo, Inc., a global food and beverage company, as Global Chief Information Officer and Senior Vice President from 2007 through 2016. Previously, Mr. Dixon held various positions with The Procter & Gamble Company, a consumer household products company, since 1977, including Vice President of Global Business Services. Mr. Dixon has served on the boards of Anthem, Inc., a health benefits company, since 2011, and Build-A-Bear Workshop, Inc., a specialty retailer, since February 2018. At the Georgia Institute of Technology, Mr. Dixon serves on the President’s Advisory Board, the College of Engineering Advisory Board and the College of Computing Advisory Board. He previously served on the CIO Advisory Board for IBM. Mr. Dixon holds a Bachelor of Science Degree in electrical engineering from The Georgia Institute of Technology.

What is Robert L. Dixon, Jr.'s net worth?: The estimated net worth of Robert L. Dixon, Jr. is at least $21.50 million as of September 1st, 2023. Mr. Dixon, Jr. owns 44,980 shares of Elevance Health stock worth more than $21,499,091 as of December 11th. This net worth estimate does not reflect any other investments that Mr. Dixon, Jr. may own. Learn More about Robert L. Dixon, Jr.'s net worth.
How do I contact Robert L. Dixon, Jr.?: The corporate mailing address for Mr. Dixon, Jr. and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Robert L. Dixon, Jr.'s contact information.
Has Robert L. Dixon, Jr. been buying or selling shares of Elevance Health?: Robert L. Dixon, Jr. has not been actively trading shares of Elevance Health during the past quarter. Most recently, Robert L. Dixon, Jr. sold 310 shares of the business's stock in a transaction on Friday, July 21st. The shares were sold at an average price of $476.71, for a transaction totalling $147,780.10. Following the completion of the sale, the director now directly owns 9,638 shares of the company's stock, valued at $4,594,530.98. Learn More on Robert L. Dixon, Jr.'s trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 3 times. They sold a total of 15,472 shares worth more than $6,891,844.98. The most recent insider tranaction occured on October, 24th when CAO Ronald W Penczek sold 64 shares worth more than $29,078.40. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 10/24/2023.

Robert L. Dixon, Jr. Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/21/2023	Sell	310	$476.71	$147,780.10	9,638
6/6/2022	Sell	420	$497.14	$208,798.80	9,491
5/27/2020	Sell	1,102	$284.59	$313,618.18	9,568
7/26/2019	Sell	520	$294.11	$152,937.20	9,971
5/18/2018	Sell	1,000	$231.10	$231,100.00

Robert L. Dixon, Jr. Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.

Today's Range

Now: $476.10

$468.51

$480.51

50 Day Range

MA: $460.35

$433.52

$483.14

2 Week Range

Now: $476.10

$412.00

$544.01

Volume

1,418,399 shs

Average Volume

1,166,378 shs

Market Capitalization

$111.86 billion

P/E Ratio

18.69

Dividend Yield

1.24%

Beta

0.84

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

From Autonomix | Ad

Invest in Autonomix today.